baber/WOPTO huggingface dataset:
Patent NZ-511239-A (NZ)
Title: Vitamin D analogues
Inventor: BERNARDON JEAN-MICHEL
IPC: A61K8/00
Filed: 1999-10-28
Abstract: Described are biaromatic compounds of formula (I), wherein the linking group X-Y is selected from the formulae (a) to (d), and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of dermatological conditions.
Patent NZ-512095-A (NZ)
Title: Quinoline and quinoxaline compounds
Inventor: MYERS MICHAEL R
IPC: C07D241/54
Filed: 1999-11-23
Abstract: Described is a stent device having a polymeric coating in which is incorporated a compound of formula (I) or an N- oxide, hydrate, solvate, prodrug, or salt thereof; where in the compound of formula (I): R1a is optionally substituted alkyl, hydroxy, acyloxy, optionally substituted alkoxy, optionally substituted cycloalkyloxy, optionally substituted oxaheterocyclyloxy, optionally substituted heterocyclylcarbonyloxy or halo; R1b is H, optionally substituted alkyl, hydroxy, acyloxy, optionally substituted alkoxy, optionally substituted cycloalkyloxy, optionally substituted oxaheterocyclyloxy, optionally substituted heterocyclylcarbonyloxy or halo; R1c is H, optionally substituted alkyl, optionally substituted aryl, optionally substituted heteroaryl, hydroxy, acyloxy, optionally substituted alkoxy, optionally substituted cycloalkyloxy, optionally substituted heterocyclyoxy, optionally substituted aryloxy, optionally substituted heteroaryloxy, optionally substituted heterocyclylcarbonyloxy, halo, cyano, R5R6N- or acylR5N-; R2 is optionally substituted phenyl or is optionally substituted benzyl; Za is N or CH; and Zb is NH or O. Also described is a pharmaceutical composition comprising a compound of formula (I). The compound of formula (I) is useful for preparing a stent device for treating a patient subject to restenosis, where the compound is incorporated into a polymeric material coated on the surface of the stent device. Also described are certain compounds of formula I.
Patent NZ-512793-A (NZ)
Title: Method of cleaning and cleaning system for food processing apparatus using pulsed gas and liquid
Inventor: WALKER MICHAEL LAWRENT GALWEY
IPC: B08B9/02
Filed: 2001-07-05
Abstract: The cleaning system (1) for cleaning industrial food processing equipment or components comprises firstly of applying a cleaning liquid to the food processing equipment or components. The cleaning liquid is fed to the equipment through a transfer line provided with a means of injecting gas under pressure (6). This means of injecting gas under pressure works by injecting pulses of pressurised gas that accelerate the cleaning liquid and increases the cleaning force. Also, to prevent back flow of the cleaning liquid, the transfer line employs valves (7) in the upstream portion of the gas injecting means of the transfer line.
Patent NZ-513752-A (NZ)
Title: Bin structures and their formation
Inventor: HEWITT WALLACE NORMAN
IPC: A47G29/06
Filed: 2001-08-22
Abstract: Bin walls have splayed end extensions so as four such walls can form a bin with reinforced and lapped joints with the bin having the appearance of a rectangle or square with truncated corners when viewed in plan.
Patent NZ-515711-A (NZ)
Title: Combination of tumors necrocis factor (TNF) antagonists and COX-2 inhibitors for the treatment of inflammation
Inventor: KEANE J
IPC: A61K31/4015
Filed: 2000-06-26
Abstract: The present invention provides combinations of a tumor necrosis factor antagonizing agent and a cyclooxygenase-2 inhibiting agent for treating inflammatory disease in a mammal.
Patent NZ-516712-A (NZ)
Title: Prophylactic dietary supplement based on milk
Inventor: ELLIOTT ROBERT BARTLETT
IPC: A23L1/305
Filed: 2000-06-29
Abstract: A dietary supplement comprising bovine milk or a bovine milk product having a â-casein content, where the milk or milk product is fortified. This dietary supplement, when consumed reduces plasma levels of homocysteine and reduces the incidence of vascular disease in a mammalian population.
Patent NZ-518958-A (NZ)
Title: Device and method for removal of rust and paint by means of induction heat
Inventor: ALVEBERG BJORN ERIK
IPC: H05B6/10
Filed: 2000-11-01
Abstract: A method for removal of rust and paint from a metal surface (3), wherein induction heat is provided by an induction coil (1) that is moved along the metal surface (3) and the supplied amount of energy per surface area is constant independent of the induction coil velocity along the metal surface.
Patent NZ-520962-A (NZ)
Title: 5-alkylpyrido[2,3-d]pyrimidines cyclin-dependent tyrosine kinase inhibitors
Inventor: BOOTH RICHARD JOHN
IPC: A61K31/519
Filed: 2001-01-29
Abstract: Disclosed are compounds of the formula (I) wherein: R2 is hydrogen, alkyl, or cycloalkyl; R3 is hydrogen, lower alkyl, lower alkoxy, halogen, trifluoromethyl, lower alkynyl, lower alkenyl, nitrile, nitro, -COR4, -CO2R4, -CONR4R5, -CONR4R4OR5, -SO2NR4R5, - SO2NR4R5, -SO2R4, -SO3R4, P(O)(OR4)(OR5), or -NR4R5; Y is N or CR7; R9 is lower alkyl, haloalkyl, or aryl; X and Z are independently hydrogen, halogen, lower alkyl, lower alkoxy, trifluoromethyl, hydroxy, nitrile, nitro, - NR4R5, -N(O)R4R5, -NR4R5R6W, -SR4, -C(O)R4, -CO2R4, - CONR4R5, -SO2NR4R5, -SO2R4, -SO3R4, P(O)(OR4)(OR5), - T(CH2)mQR4, -C(O)T(CH2)mQR4, or -NR4C(O)T(CH2)mQR5; m is 1 to 6 and all other variables are as described in the specification. These compounds are useful for treating cell proliferative disorders, such as cancer, atherosclerosis, and restenosis. These compounds are potent inhibitors of cyclin-dependent kinases (cdks) and growth factor-mediated kinases.
Patent NZ-521238-A (NZ)
Title: Sewage pump-out tank spray-cleaning system
Inventor: MCCASKER DOUGLAS BRETT
IPC: B01D17/02
Filed: 2000-02-09
Abstract: A swage well-cleaning system (10) includes a rotary spray device (11) rotatably mounted on a support arm (12) in a swage well (20) and connectable to a cleaning liquid supply by a selectively operable liquid control valve (17), a liquid waste pump (21) in the well and a control system including: a first waste liquid level sensor in the well detecting when waste liquid has been pumped from the well by the liquid waste pump; a control unit (34), operably connected to the cleaning liquid control valve (17); and a first timer (39) and a second timer (40) operably connected to the control unit; so arranged that when the first waste liquid level sensor detects that waste liquid has been pumped from the well by the pump, the control unit operates the cleaning liquid control valve, to allow cleaning liquid to flow to the rotary spray device to clean the well, with a wash cycle having a duration determined by the second timer (40), the first timer (39) preventing the control unit initiating a further wash cycle until the elapse of a preset period.
Patent NZ-521919-A (NZ)
Title: Apparatus and method for measuring and correlating characteristics of fruit with visible/near infra-red spectrum
Inventor: OZANICH RICHARD M
IPC: G01N21/35
Filed: 2001-03-12
Abstract: The visible and near infra-red spectrum from 250 nm to 1150 nm is utilised for simultaneous determination of a plurality of characteristics such as brix, firmness, acidity, density, pH, colour and external and internal defects in produce such as fruit. The interior of the produce is irradiated with a frequency spectrum and the spectrum absorbed and scattered from the sample is detected and compared with predetermined spectral characteristics to determine the multiple characteristic values for the sample. In particular, the visible pigment region, including xanthophyll, from approximately 250 nm to 499 nm and anthocyanin from approximately 500 to 550 nm, in combination with the chlorophyll band peaking at 680nm and the spectrum from 700 nm and above is utilised to predict all of the above characteristics.
Patent NZ-523066-A (NZ)
Title: Fused azepine derivatives and their use as antidiuretic agents
Inventor: ASHWORTH DOREEN MARY
IPC: A61P25/00
Filed: 2001-06-21
Abstract: Compounds of formulae 1 and 2, wherein W is N or C-R4, G1 is selected from the formulae 3 to 8, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of diseases mediated by an agonist of vasopressin.
Patent NZ-523221-A (NZ)
Title: Canine hepatocyte growth factor
Inventor: MIYAKE MASASHI
IPC: A61P9/00
Filed: 2001-06-22
Abstract: Described are: canine hepatocyte growth factor and a 5 amino acids-deleted canine hepatocyte growth factor thereof and the genes encoding these factors, a method for producing the hepatocyte growth factors characterized in that it comprises culturing a non-human transformant comprising a recombinant vector comprising the canine hepatocyte growth factor genes, and collecting a canine hepatocyte growth factor from the obtained culture, and a pharmaceutical preparation comprising a canine hepatocyte growth factor for the treatment of non-human liver diseases, kidney diseases, lung diseases, bone diseases, digestive diseases, cardiocirculatory diseases or cranial nerve diseases.
Patent NZ-527229-A (NZ)
Title: Three-wheeled stroller with releasable catches to allow relative sliding of frame members combined with pivoting to collapse stroller
Inventor: EVERETT RICHARD C
IPC: B62B7/06
Filed: 2003-07-28
Abstract: In order to collapse the stroller buttons (not shown) on the interconnect members 54,56 are pressed. This allows sliding of members 33,34 relative to members 36,38. Members 24,26 thus pivot forwardly and down relative to axle 22, and members 36,38 pivot down relative to front pivot connections.
Patent NZ-530614-A (NZ)
Title: Azole compounds as therapeutic agents for fungal infections
Inventor: ARORA JASBIR SINGH
IPC: A61K31/41
Filed: 2001-03-01
Abstract: Described are derivatives of specially substituted azole compounds which have improved antifungal activity as compared to known compounds such as fluconazole and itraconazole and the processes for the preparation thereof. Also described are pharmaceutical compositions containing the compounds of the present invention and their use in treating and/or preventing fungal infections in mammals, preferably humans.
Patent NZ-532527-A (NZ)
Title: Nicotine-containing pharmaceutical composition comprising cocoa powder
Inventor: LINDBERG NILS-OLOF
IPC: A61P25/28
Filed: 2002-09-10
Abstract: A nicotine-containing pharmaceutical composition that comprises at least 17% cocoa powder, process for manufacturing the composition and use of the composition in therapies, such as nicotine replacement therapy, weight control therapy, treatment of Alzheimer's disease, Parkinson's disease, ulcerative colitis and/or Tourette's syndrome.
Patent NZ-538264-A (NZ)
Title: Food product and process for retaining moisture in cooked food
Inventor: KELLEHER STEPHEN D
IPC: A23L13/60
Filed: 2003-07-01
Abstract: A process for retaining moisture in uncooked animal muscle tissue during cooking of the animal muscle tissue comprising: (a) adding to the uncooked animal muscle tissue a protein mixture selected from the group consisting of an aqueous acidic protein solution , having a pH of about 3.5 or less, of myofibrillar proteins and sarcoplasmic proteins derived from animal muscle tissue, a dry protein mixture of myofibrillar proteins and sarcoplasmic proteins derived from animal muscle tissue obtained by drying the aqueous acidic protein solution and mixtures thereof by an adding method selected from the group consisting of applying said protein mixture to at least one surface of said uncooked animal muscle tissue, mixing the protein mixture with the uncooked animal tissue, injecting the protein mixture into the uncooked animal muscle tissue and a combination of least two of the adding methods; and (b) cooking the uncooked animal muscle tissue and protein mixture from step (a).
Patent NZ-541367-A (NZ)
Title: Human SAA3 nucleic acid molecule, protein, and methods of use for same
Inventor: MCDONALD THOMAS L
IPC: C12N5/08
Filed: 2004-01-21
Abstract: Provided is an isolated nucleic acid molecule, said molecule encoding an SAA3 protein of a specified amino acid sequence. Also provided are isolated host cells comprising vectors containing the said nucleic acid, methods of inducing transcription of a heterologous sequence using the first 56 nucleotides of the said nucleic acid molecule and isolated polypeptides having SAA3 activity. Further provided is the use of the polypeptide in the manufacture of medicaments for the treatment or prevention of enteric infections.
Patent NZ-541936-A (NZ)
Title: Wind turbine
Inventor: GRACE PAUL DAVID
Filed: 2005-11-22
Abstract: A wind turbine including; a rotor mounted for rotation about a first axis; at least one blade mounted to the rotor and pivotable about a second axis wherein more than half of the path circumscribed by said blade in a revolution of the rotor is substantially unshrouded, and characterised in that the turbine includes at least one restraint engageable with the, or each blade to at least partially constrain the pivotal movement of the or each blade to within a predetermined angular range relative to the rotor, and wherein the, or each restraint may be disengaged to permit the blade to pivot substantially freely outside said predetermined angular range.
Patent NZ-542392-A (NZ)
Title: Trip indicative rocker switch
Inventor: FERREIRA CARLOS ALBERTO
Filed: 2005-09-15
Abstract: A switch mechanism such as a circuit breaker includes a trip indicator mechanism. The switch mechanism includes a switch contact and a rocker movable between a first position in which the contacts are closed, a second position indicating that an electrical fault has occurred, in which the contacts are open, and a third position in which the switch mechanism has been reset and the contacts are open. The rocker preferably comprises two rocker members hinged together with one of the rocker members having a step formation between a front face and an end face. The step formation carries an instruction regarding resetting of the mechanism and lies substantially flush with the front panel of the circuit breaker housing, with the face of the first rocker member standing partially proud of the front panel, when the rocker is in the second position. The mechanism allows a user to distinguish between manual switching off of the circuit breaker and tripping due to a fault.
Patent NZ-547386-A (NZ)
Title: Air-bubble-monitoring medication assembly, medical system and method
IPC: A61M5/36
Filed: 2004-11-26
Abstract: An air-bubble-monitoring medication assembly (10) is disclosed which comprises: a) a drug infusion subassembly (12) that has a tube (18) for administering therein a liquid (20) to a patient (22); b) a bubble-size determinator (14) which is disposed to sense an air bubble (24) above a minimum size entrained in the liquid (20) in the tube (18), and which determines the volume of the sensed air bubble (24); and c) an analyzer (16) which logs the time the bubble-size determinator (14) senses an air bubble (24) and the volume of the sensed air bubble (24), which calculates a first running sum of a total air volume of all air bubbles sensed over a first time interval, and compares the first running sum with a first preselected limit, where the analyzer (16) generates an output when the first running sum exceeds the first preselected limit.
Patent NZ-548244-A (NZ)
Title: Bayonet type adapter assembly for the supply cup of a spray gun
Inventor: KOSMYNA MICHAEL J
IPC: B05B7/24
Filed: 2004-12-03
Abstract: An adapter assembly for connecting a fluid supply assembly to a fluid applicator. The adapter assembly includes an outer lid (508) for the fluid supply assembly and an adapter. The adapter assembly provides a connection between the fluid supply assembly and the fluid applicator that can be engaged quickly, easily, and securely, and which has a strong tight seal around the connection.
Patent NZ-551284-A (NZ)
Title: Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors
Inventor: AGUILAR IZQUIERDO NURIA
IPC: C07D495/04
Filed: 2005-06-21
Abstract: Disclosed is pyridazine-3(2H)-one derivatives of formula (I) wherein the substituents are disclosed within the specification. Also disclosed is the use of a compound of formula (I) in the manufacture of a medicament for the treatment or prevention of a pathological condition or disease susceptible to amelioration by inhibition of phosphodiesterase 4.
Patent NZ-553783-A (NZ)
Title: Interengagement system for helments
Inventor: SPINK GLEN
IPC: A42B3/00
Filed: 2007-03-09
Abstract: A visored helmet assembly (1) including: a helmet having exposed on a flank an engagement member (2), a complementary member (3) adapted to be slideably engaged on or about the engagement member so as to be retained thereby, a visor (5) having a non-rotational opening (6), a member (7) adapted to locate non-rotatably in the non-rotational visor opening, and a locking member (8) to co-act with the member, yet to affix into the complementary member, such locking member having an ability to rotate relative to the member, wherein that rotation is of a detent or frictional inter-engagement form, and wherein the visor can be rotated about an axis yet be retained by either (i) the locking member and the member or (ii) by the locking member, the member and the complementary member.
Patent NZ-562515-A (NZ)
Title: Cover plate and group of parts, including such plate, for the wall mounting of an electrical apparatus
Inventor: FABRIZI FABRIZIO
IPC: H02G3/12
Filed: 2006-04-03
Abstract: A cover plate (1, 21) for the wall application of at least one electrical apparatus (20) is disclosed. The cover plate is characterised in that it comprises: - a base (2), a mask (4), and at least one fixing element. The base has a through opening (3) adapted to receive a front portion of at least one electrical apparatus (20). The mask (4), which can be coupled to the base (2), is equipped with a window (5) cooperating with the through opening (3) and it too is adapted to receive a front portion of an electrical apparatus (20).The at least one fixing element (6) includes a first portion (9) adapted to project inside the window towards the base (2) and comprising coupling means (10, 14) of the element to the base (2). The fixing element includes (6) moreover a second portion (7) adapted to cooperate with at least one surface portion (8) of the mask (4) facing the window (5) to fix the base (2) to the mask (4).
Patent NZ-563164-A (NZ)
Title: Triazine-based affinity adsorbents for fibrinogen
Inventor: BETLEY JASON RICHARD
IPC: B01J20/286
Filed: 2006-05-09
Abstract: Disclosed is the use of a triazine based affinity adsorbent of formula II for the separation, removal, isolation, purification, characterisation, identification or quantification of fibrinogen or a protein that is a fibrinogen analogue in vitro. The variables are as disclosed in the specification. Also disclosed are particular compounds of formula II as disclosed in the specification.
Patent NZ-564186-A (NZ)
Title: Absorbent article such as diaper with ultrasonic weld seam reinforced for high transverse strength
Inventor: EDWALL KERSTIN
IPC: A61F13/15
Filed: 2005-07-14
Abstract: The present disclosure provides an absorbent article such as a diaper, pant diaper, a sanitary pant or incontinence garment. The article comprises at least one first elastic web material which is ultrasonically welded to at least one second web material along at least one weld seam. The second web material is different to the first elastic web material and said second web material has a degree of elasticity which is different to the elasticity of the first elastic web material. According to the invention, the ultrasonic weld seam between the first elastic web material and the second web material is reinforced to have a weld strength in a direction transverse to the weld seam which is at least 5N/25.4mm. The disclosure particularly relates to pant-type absorbent articles.
Patent NZ-565910-A (NZ)
Title: Optimizing the detection of tollable vehicles on toll roads
Inventor: PETROCZI JULIUS
IPC: G07B15/00
Filed: 2006-08-01
Abstract: Disclosed is a method for optimizing the detection of vehicles liable to pay tolls on toll roads of a road network. The method includes using a vehicle-mounted position determining unit connected to a vehicle external management unit. Toll roads are overlaid in an electronic image of the road network by detection zones (E), and the position determining unit, upon determining vehicle positions (PE) within the detection zones, determines toll-related data and sends the data to the management unit. Monitoring zones (K) are also provided in the image, and are assigned to and extend beyond their assigned detection zone. The position determining unit, upon determining journeys exclusively within the monitoring zone and outside the detection zone, sends position data (P-K-) of the journeys to the management unit. The management unit then performs a retrospective check of the position data (PK-) to determine whether the detection zone should be adjusted, and adjusts if necessary.
Patent NZ-566083-A (NZ)
Title: Methods and compositions for prevention and treatment of diabetic and aged skin
Inventor: TENNENBAUM TAMAR
IPC: A61K35/12
Filed: 2006-08-29
Abstract: Disclosed is a method for preventing a skin pathology, disorder or condition associated with diabetes and/or aging in a non-human animal, comprising topically administering to the skin of a diabetic and/or aging non-human animal a therapeutically or cosmetically effective amount of at least one agent capable of restoring an impaired physiological condition of the skin associated with said skin pathology, disorder or condition selected from the group consisting of a PKC iso form modulator, an adipokine, PPARy, a PPARy agonist or antagonist, and an agent capable of modulating the expression and/or activity of a factor involved in the insulin signalling pathway in the skin; with the proviso that said agent is not IL-4.
Patent NZ-580646-A (NZ)
Title: Metabolites of (thio)carbamoyl-cyclohexane derivatives
Inventor: AGAINE CSONGOR EVA
IPC: C07D295/24
Filed: 2008-05-15
Abstract: Disclosed is a carbamoyl-cyclohexane compound of formula (I) where the substituents are as disclosed in the specification. Example of compounds of formula is trans-1- { 4-[2-[ 4-(2,3-dichloro-4-methoxy-phenyl)-piperazin-1-yl]-ethyl]-cyclohexyl } -urea. Also disclosed is a pharmaceutical composition comprising a compound of formula (I) and the use of a compound of formula (I) in the manufacture of a medicament for treatment and/or prevention of a condition which requires modulation of a dopamine receptor selected from the group consisting of psychoses (e.g, schizophrenia, schizo-affective disorders) , cognitive impairment accompanying schizophrenia, mild-to-moderate cognitive deficits, dementia, psychotic states associated with dementia, psychotic depression, mania, paranoid and delusional disorders, obsessive compulsive disorders, dyskinetic disorders such as Parkinson's disease, neuroleptic induced parkinsonism, tardive dyskinesia, eating disorders (e.g. bulimia nervosa), attention deficit disorders, hyperactivity disorders in children, depression, anxiety, sexual dysfunction, sleep disorders, emesis, aggression, autism and drug abuse.